Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair

被引:0
作者
Tetsu Tanaka
Refik Kavsur
Atsushi Sugiura
Johanna Vogelhuber
Can Öztürk
Marcel Weber
Vedat Tiyerili
Sebastian Zimmer
Georg Nickenig
Marc Ulrich Becher
机构
[1] University Hospital Bonn,Department of Internal Medicine II, Heart Center Bonn
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hepatorenal dysfunction is a strong risk factor in patients with heart failure (HF). We investigated the prognostic significance of hepatorenal dysfunction in 172 consecutive patients undergoing transcatheter tricuspid valve repair (TTVR). The model for end-stage liver disease excluding international normalized ratio (MELD-XI) score was calculated as 5.11 × ln(serum total bilirubin [mg/dl]) + 11.76 × ln(serum creatinine [mg/dl]) + 9.44. Patients were stratified into two groups: high (≥ 14) or low (< 14) MELD-XI score, according to the best cut-off value to predict a one-year composite outcome consisting of all-cause mortality and HF hospitalization. Compared to patients with low MELD-XI score (n = 121), patients with high MELD-XI score (n = 51) had a higher incidence of the composite outcome (47.1% vs. 17.4%; p < 0.0001). In the multivariable analysis, the MELD-XI score was an independent predictor of the composite outcome (adjusted hazard ratio: 1.12; 95% confidence interval [CI] 1.05–1.19; p = 0.0003). In addition, post-procedural TR < 3 + after TTVR was independently associated with a reduction in MELD-XI score six months after TTVR (adjusted odds ratio: 3.37; 95% CI 1.09–10.40; p = 0.03). Thus, the MELD-XI score was associated with the risk of one-year composite outcome, consisting of mortality and HF hospitalization, after TTVR and may help the risk stratification in patients undergoing TTVR.
引用
收藏
相关论文
共 47 条
  • [1] Chorin E(2020)Tricuspid regurgitation and long-term clinical outcomes Eur. Heart J. Cardiovasc. Imaging 21 157-165
  • [2] Topilsky Y(2019)Burden of tricuspid regurgitation in patients diagnosed in the community setting JACC Cardiovasc. Imaging 12 433-442
  • [3] Topilsky Y(2014)Clinical outcome of isolated tricuspid regurgitation JACC Cardiovasc. Imaging 7 1185-1194
  • [4] Dreyfus J(2020)Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes Eur. Heart J. 41 4304-4317
  • [5] Axtell AL(2019)Surgery does not improve survival in patients with isolated severe tricuspid regurgitation J. Am. Coll. Cardiol. 74 715-725
  • [6] Taramasso M(2019)Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation J. Am. Coll. Cardiol. 74 2998-3008
  • [7] Taramasso M(2017)The international multicenter trivalve registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc. Interv. 10 1982-1990
  • [8] Nickenig G(2019)Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study Lancet 394 2002-2011
  • [9] Fam NP(2019)Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience JACC Cardiovasc. Interv. 12 2488-2495
  • [10] Nickenig G(2017)Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique Circulation 135 1802-1814